Device Tissue Diagnostics

Ventana He 600 System

Payments companies reported to CMS as associated with Ventana He 600 System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$333associated payments (2023-2025)
13clinicians with associated payments
1company reporting

By year

2023 $104
2024 $158
2025 $71.17

Payments reported as associated with Ventana He 600 System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Anatomic Pathology & Clinical Pathology $207
Dermatopathology (Pathology) $61.32
Hematology (Pathology) $26.65
Dermatology $21.30
Anatomic Pathology $17.03

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ventana He 600 System

These are the largest totals companies reported as associated with Ventana He 600 System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Qi Wang New Brunswick, NJ Anatomic Pathology & Clinical Pathology $49.96
Honggang Shen Los Angeles, CA Dermatopathology (Pathology) $40.03
Nicholas Barasch New York, NY Hematology (Pathology) $26.65
Siavash Samimi Chico, CA Anatomic Pathology & Clinical Pathology $26.65
Adam Perricone Huntsville, AL Anatomic Pathology & Clinical Pathology $25.33
Priya Gore Huntsville, AL Anatomic Pathology & Clinical Pathology $25.33
Abhijeet Chaubal New Brunswick, NJ Anatomic Pathology & Clinical Pathology $24.97
John Moesch Savannah, GA Dermatology $21.30
Drazen Jukic Savannah, GA Dermatopathology (Pathology) $21.29
Allison Wasserman Springfield, MA Anatomic Pathology & Clinical Pathology $20.51

Prescribed Ventana He 600 System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.